戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              MFI for CD18 was decreased in both CD4+ and CD8+ T cells
2                                              MFI varied according to manufacturer, kit, bead type and
3 ning for anti-HLA antibodies using the 3,000 MFI threshold may be important in managing transplant ca
4 hout leakage (PPV, 88.1% vs 90.6% [P = .01]; MFI, 2.1 vs 2.4 [P = .007]), most markedly during the cr
5 arkers in a diverse cohort, baseline sICAM-1 MFI is associated with HCC incidence.
6 e age, antiviral treatment, and high sICAM-1 MFI; on multivariate analysis, sICAM-1 remained associat
7        The growth mechanism of silicalite-1 (MFI zeolite) is juxtaposed between classical models that
8  intercellular adhesion molecule 1 (sICAM-1) MFI.
9  suggested optimal cutoffs from 1000 to 1500 MFI.
10 ly in recipients with DSAs greater than 2000 MFI in the second run.
11 ph nodes had reduced Foxp3 expression (> 25% MFI loss) and increased IL-17A expression (> 15%), compa
12 he formation of functional membranes from 2D MFI nanosheets.
13                              High-quality 2D MFI nanosheet coatings were prepared on alpha-alumina ho
14 nsity (MFI), 7/19 were between 1000 and 3000 MFI, and one was >3000 MFI.
15 between 1000 and 3000 MFI, and one was >3000 MFI.
16 fluorescence intensity (MFI) versus 42 +/- 4 MFI for stimulated GP IIb/IIIa expression (p < 0.001).
17  an increase in the inducibility of pSTAT-4 (MFI 157 vs 173; P=0.0002).
18 ients, an increase in nCD64 expression >/=40 MFI predicted intensive care unit (ICU)-acquired infecti
19  sAMR were MFI of immunodominant DSA > 4000, MFI of the sum of DSA > 6300, age of the recipient < 45
20 e sAMR were MFI of immunodominant DSA >4000, MFI of the sum of DSA >6300, age of the recipient <45 ye
21 ter therapy (mean decrease of 1916 [SE, 425] MFI, P < 0.01).
22 1.38-3.43; P = 0.0008), DSA greater than 500 MFI at transplant (HR, 1.64; 95% CI, 1.05-2.57; P = 0.03
23 threshold was increased to greater than 8000 MFI, because no matches were found with standard allocat
24 roup, one patient developed de novo DSA (A24-MFI 970; biopsy for cause did not show biopsy-proven acu
25 bindings of l- and d-lysine (Lys) in achiral MFI zeolites.
26 dissociation inhibitor 2 (ARHGDIB) (adjusted MFI [aMFI]>=1000), a minor histocompatibility antigen, a
27 ntibodies (sensitization) were defined by an MFI of more than 1000.
28       If the thresholds were increased to an MFI of 2000 or less and 5000 or less, an extra 6.4 and 6
29               Increasing the threshold to an MFI of 2000 or less may provide an acceptable balance fo
30 as background) cutoff of 15 combined with an MFI cutoff of 500, resulting in 8% and 21% lower 1- and
31 group, mean peak panel reactive antibody and MFI at transplant were 51% +/- 7% and 960 +/- 136, respe
32 etween platelets count and both of CD62P and MFI.
33 nstrate that wNMR outperformed SEC, DLS, and MFI in that it was most consistently sensitive to increa
34 y a single conformer was found (BEA, LTA and MFI).
35                            Using Luminex and MFI quantification, anti-HLA antibodies are common befor
36 ine nanosheets of zeolite frameworks MWW and MFI.
37                                      PPV and MFI were correlated with the endothelial activation mark
38 e bis-imidazolium cation with n = 4, TON and MFI were also obtained, and again two (19)F MAS NMR reso
39 munodominant, but not the sum, of antibodies MFI.
40 3,000 (group III), and 24% had antibodies at MFI 1,000 to 3,000 (group II).
41 e cases with a posttransplant DSA peaking at MFI >2000 U on microbead assay, rejection did not occur.
42  a CNN for muscle segmentation and automatic MFI calculation using high-resolution fat-water images f
43                     Single antigen flow bead MFI thresholds allowing XM positivity to be predicted we
44 of predominantly amorphous aggregates before MFI crystallization.
45              There is no association between MFI levels and development of complications after LT.
46 iled consideration of the structures of both MFI, and a closely related material MEL, lead to the pro
47 ts contract upon calcination similar to bulk MFI crystals.
48 iated with AAD, but the quantity assessed by MFI levels may play a role.
49 he pronounced increase in particle count (by MFI).
50 proved all other fatigue aspects measured by MFI, including Physical Fatigue and Mental Fatigue (acup
51                                         CD63 MFI expression was reduced from 68 248 (29 336-92 001) t
52                            Additionally, CNN MFI was higher in participants with persisting pain and
53 relationships between CNN muscle volume, CNN MFI, and clinical measures of pain and neck-related disa
54 isability (R = -0.286, p = 0.045), while CNN MFI tended to be positively correlated to disability (R
55 verted to C1q - when diluted to a comparable MFI level as the C1q - DSA from AMR- patients, and some
56 examining interaction effects, and comparing MFI distribution between groups.
57                         Manganese-containing MFI-type Mn-ZSM-5 zeolite was synthesized by a facile on
58 o those of other mesoporous and conventional MFI zeolites.
59                         A highly crystalline MFI zeolite structure was formed under pH = 11 in 2 days
60 ered silicate moieties and the crystallizing MFI zeolite nanosheet framework.
61 hter structures of higher framework density (MFI) under hydrothermal conditions.
62 sk of AMR is higher in patients with a dnDSA MFI level that is greater than 3,000.
63 on at 1 year was 30% in the group with dnDSA MFI level of 3,000 or greater but only 4% for the group
64                                          DSA MFI greater than 10 000 versus MFI 1000 to 10 000 at 1 y
65                                          DSA MFI values increased at the time of AAD and returned to
66 d significantly higher IgG, C1q, and C3d DSA MFI than nonrejecting or C4d-negative patients, respecti
67 m of mean fluorescence intensity of DSA (DSA MFI-Sum) of 6,000 or higher (OR, 18; 95% CI, 7.0-47; P <
68 as 2.03 (95%CI, 1.05-3.92; P = 0.04) for DSA MFI-Sum of 6,000 or higher and 2.23 (95% CI, 1.04-4.80;
69 1.73 m(2) per log10 increase in Class II DSA MFI (p < 0.01).
70 t class II DSA, those with IgG4 class II DSA MFI sum >2000 exhibited an odds ratio (OR) of 20.79 (95%
71  protocols based on their immunodominant DSA MFI pretransplant (D1: 100-500, D2: 501-1000, and D3: 10
72 ter evaluated through the immunodominant DSA MFI than through the sum of DSA MFI.
73        High-dose IVIG resulted in modest DSA MFI reductions in patients with previous graft damage, w
74 dominant DSA MFI than through the sum of DSA MFI.
75 red with 4 of 7 (57%) patients with peak DSA MFI 2000 to 7000U, and 2 of 12 (17%) patients with peak
76 0U, and 2 of 12 (17%) patients with peak DSA MFI less than 2000U (P<0.02).
77                    Our data suggest that DSA MFI and presence of intragraft DSA might provide prognos
78                  Our study suggests that DSA MFI-Sum and HLA class of DSA are characteristics predict
79 on from January 2000 to April 2009, had DSA (MFI >/=1000) in serum 10 to 14 months postliver transpla
80 riable regression analysis that included DSA-MFI-Sum or HLA DSA class.
81 nts are indeed due to significantly enhanced MFI-polymer adhesion and distribution of MFI crystals.
82 th MFI structure reveals that the exfoliated MFI nanosheet is 1.5 unit cells (3.0 nm) thick and wrink
83 h other MFI membranes prepared from existing MFI materials (such as exfoliated nanosheets or nanocrys
84 for MFI >/=100 vs. 4.7[2.4-8.8], P<0.001 for MFI >/= 800).
85 from MFI 100 to 800 (1.7[0.8-3.2], P=0.1 for MFI >/=100 vs. 4.7[2.4-8.8], P<0.001 for MFI >/= 800).
86 eactivity and selectivity, also inferred for MFI from titration of OH groups by Na(+), have not been
87 rely at the pH and temperatures required for MFI synthesis.
88                       The obtained OSDA-free MFI nanosheets disperse well in water and can be used fo
89 eased linearly with higher class II DSA from MFI 100 to 800 (1.7[0.8-3.2], P=0.1 for MFI >/=100 vs. 4
90 s of high-quality, mesoporous zeolite (e.g., MFI-type) nanocrystals is presented, based on a biomass-
91                              Between groups, MFI trends were analyzed.
92 lites without 8-MR channels (H-BEA, H-FAU, H-MFI).
93 genation and cracking are examined over Ga/H-MFI catalysts prepared via vapor-phase exchange of H-MFI
94 action conditions, [GaH](2+) cations in Ga/H-MFI exhibit a turnover frequency for C(3)H(8) dehydrogen
95 rogenation to the rate of cracking over Ga/H-MFI is independent of C(3)H(8) and H(2) partial pressure
96 tions exhibit first-order kinetics over Ga/H-MFI only at very low C(3)H(8) partial pressures and zero
97  both dehydrogenation and cracking over Ga/H-MFI via reaction with [GaH](2+) cations to form [GaH(2)]
98 n and cracking of C(3)H(8) proceed over Ga/H-MFI via reversible, heterolytic dissociation of C(3)H(8)
99       H(2) inhibits both reactions over Ga/H-MFI.
100 n the locations of exchangeable cations in H-MFI and on the monomolecular cracking and dehydrogenatio
101 lysts prepared via vapor-phase exchange of H-MFI with GaCl(3).
102 der kinetics with respect to C(3)H(8) over H-MFI, but both reactions exhibit first-order kinetics ove
103 he corresponding turnover frequencies over H-MFI.
104 g zeolites with varying channel structure (H-MFI, H-FER, H-MOR) and between OH groups within eight-me
105 tivity of alkane cracking catalysis in the H-MFI zeolite is investigated using both static and dynami
106 panol (0.075-4 kPa) was studied on zeolite H-MFI (Si/Al = 26, containing minimal amounts of extra fra
107 s follows: 66% had MFI 1000 to 4999, 14% had MFI 5000 to 10 000, and 20% had MFI greater than 10 000.
108 999, 14% had MFI 5000 to 10 000, and 20% had MFI greater than 10 000.
109  of DSA+ recipients were as follows: 66% had MFI 1000 to 4999, 14% had MFI 5000 to 10 000, and 20% ha
110  presence of anti-HLA antibodies at the high MFI threshold (>3,000) was associated with lower transpl
111 ggest that DSA-sensitized patients with high MFI levels can receive transplantation across the HLA-ba
112                HLA class II Ab show a higher MFI (median: 5.300) compared to HLA class I Ab (median:
113  DSA+ patients regardless of MFI, and higher MFI at 1 year predicts DSA persistence at 5 years.
114     C1q + DSA exhibited significantly higher MFI values regardless of whether they were from AMR+ or
115 dominant DSA (iDSA, the DSA with the highest MFI level) was 6724+/-464, and 41.6% of patients had iDS
116 nvestigate water infiltration in hydrophobic MFI zeolites with different concentration of hydrophilic
117                                          IgG MFI was analyzed after elimination of prozone effect, an
118 cipients and conclude that assessment of IgG MFI may add predictive accuracy, without an independent
119 e highest accuracy was computed for peak IgG MFI (AMR, 0.73; C4d + AMR, 0.71).
120                                       IgGpan MFI alone showed a very strong association with standard
121                                       IgGpan MFI greater than 14,154 predicted standard C1q positivit
122    Combining all IgG subclass MFI and IgGpan MFI only marginally improved the prediction of standard
123 standard C1q positivity compared with IgGpan MFI alone (Deltar=0.02).
124 ssociation of AHG C1q positivity with IgGpan MFI was less strong (r=0.51).
125 ng on SAB is strongly associated with IgGpan MFI.
126 vival was detected in patients with class II MFI more than or equal to 1000 (75% vs. 91.9%, P=0.055).
127  were only evident in patients with class II MFI more than or equal to 500 (estimated glomerular filt
128 al), was investigated by micro-flow imaging (MFI) during freeze-thaw cycling in phosphate buffered so
129 ion chromatography (SEC), microflow imaging (MFI), and dynamic light scattering (DLS), and water NMR
130 ion chromatography (SEC), microflow imaging (MFI), and dynamic light scattering (DLS).
131 ex 2200 MMRV IgG multiplex flow immunoassay (MFI; Bio-Rad Laboratories, Hercules, CA) and matched imm
132 rate structure-direction effect for n = 4 in MFI, with each imidazolium ring, in two different orient
133 LF compared with blood (median difference in MFI 1337, p=0.0020) and that of CXCR2, CCR1, CCR2, and C
134  Periodic DFT calculations suggest that F in MFI resides always in the [4(1)5(2)6(2)] cages, with the
135 gely dissimilar intensities were observed in MFI.
136           The higher activity in BEA than in MFI for dehydration of a tertiary alkanol, 2-methyl-2-he
137 fused vessels (PPV) and the mean flow index (MFI) were lower in patients with dengue with plasma than
138 istribution of neck muscle fat infiltration (MFI) in the deep cervical extensor muscles (multifidus a
139                     Muscle fat infiltration (MFI) of the deep cervical spine extensors has been obser
140 tation, class I/II distribution, and initial MFI).
141 rrelate with success of treatment if initial MFI values were >10 000, likely due to single antigen be
142 e single-line manifold micro flow injection (MFI) systems.
143 antibodies (DSA) mean florescence intensity (MFI) greater than 10 000 and requires confirmation in pa
144         Cytokine mean florescence intensity (MFI) was the primary predictor and HCC development the p
145 b is measured as mean florescence intensity (MFI).
146 el of DSA had median fluorescence intensity (MFI) >2000 U, in 6 of 10 when the microbead MFI >4000 U.
147 ears) and lower mean fluorescence intensity (MFI) (2658, 1573-3819 vs. 7820, 5166-11 990).
148 ion between SAB mean fluorescence intensity (MFI) and complement assays positivity, presence of gDSA,
149 haracterized by mean fluorescence intensity (MFI) and normalized subclass composition (>5%).
150 ) more than 100 mean fluorescence intensity (MFI) at the time of transplant is associated with a sign
151 ession of 230 median fluorescence intensity (MFI) identified sepsis with a sensitivity of 89% (81%-94
152 esults with the mean fluorescence intensity (MFI) in Luminex class I single antigen flow beads (SAFB)
153 s with DSA at median fluorescence intensity (MFI) more than 7000U experienced rejection, compared wit
154 munologic risk, mean fluorescence intensity (MFI) more than or equal to 100 for class I and more than
155 lanted with DSA mean fluorescence intensity (MFI) of 500 to 1000 and greater than 1000, respectively.
156                 Mean fluorescence intensity (MFI) of 70 total DSA decreased by 12%at the end of treat
157 measured by the mean fluorescence intensity (MFI) of antibodies stored with known stabilizers.
158 nly DSAs with a mean fluorescence intensity (MFI) of greater 999 were included.
159       The dnDSA mean fluorescence intensity (MFI) of the stable function patient group (n=8; eGFR dec
160 reases in CD11a mean fluorescence intensity (MFI) on naive, central memory, and effector memory CD4+
161     Comparing median fluorescence intensity (MFI) signals for the influenza A virus and hemagglutinin
162       Change in mean fluorescence intensity (MFI) value did not correlate with success of treatment i
163 A or with a DSA mean fluorescence intensity (MFI) value of 500 or less, screening by bead-based assay
164 d sera, Luminex mean fluorescence intensity (MFI) values for IgG-SAB and C1q-SAB correlated poorly (r
165 -HLA antibodies mean fluorescence intensity (MFI) values were stable prior to BTZ (P = 0.96) but decr
166 nce of AMR, DSA mean fluorescence intensity (MFI) values, and immunoglobulin G isotype was determined
167           VLA-4 mean fluorescence intensity (MFI) varied 35-fold (range, 30 to 1,110; median, 219.5).
168  and 138 +/- 19 mean fluorescence intensity (MFI) versus 42 +/- 4 MFI for stimulated GP IIb/IIIa expr
169 onders, bAb net mean fluorescence intensity (MFI) was significantly higher with the DNA-primed regime
170  expression and mean fluorescence intensity (MFI) were highly correlated with increases in HIV-specif
171 ally from nevi [mean fluorescence intensity (MFI), 48.1; interquartile range, 41.7 to 59.6] to primar
172 1/19 were <1000 mean fluorescence intensity (MFI), 7/19 were between 1000 and 3000 MFI, and one was >
173 parallel to IgG mean fluorescence intensity (MFI), allows for improved prediction of AMR.
174 ss specificity, mean fluorescence intensity (MFI), C1q-binding, and IgG subclass, and graft injury ph
175 uantified using mean fluorescence intensity (MFI).
176 eater than 2000 mean fluorescence intensity (MFI).
177 LA antibodies at mean fluorescent intensity (MFI) greater than or equal to 3,000 (group III), and 24%
178         Peak DSA mean fluorescent intensity (MFI) levels were significantly higher at baseline (class
179 tins) and higher mean fluorescent intensity (MFI) positivity.
180 y 0 DSA levels (mean fluorescence intensity [MFI] > 3000) with a complement-dependent cytotoxicity-ne
181 n difference in mean fluorescence intensity [MFI] 703 arbitrary units [p=0.0699] for CXCR1 and 658.7
182 xpression (Deltamean fluorescence intensity [MFI] of 118.5 +/- 16.8), followed by CD11b(+)Gr-1(int) (
183 IgGpan results (mean fluorescence intensity [MFI]>500), strong complement-binding IgG1 and IgG3 subcl
184  [SFI]/10,000 median fluorescence intensity [MFI]) were determined to be unacceptable and entered int
185 SA (One Lambda, mean fluorescence intensity [MFI], >1000).
186 nding strength (mean fluorescence intensity [MFI]_max).
187  change in log median fluorescence intensity(MFI-BG) values was -0.15 overall (p < .001).
188 l infection at the maternal-fetal interface (MFI) in the early gestational stages.
189 hannels comprising a microfluidic interface (MFI) that prevents media leakage between the two dimensi
190  by in-plane XRD, indicating well-intergrown MFI films that are strongly attached to the substrate.
191                           Encapsulation into MFI via direct hydrothermal syntheses was unsuccessful b
192 ctroscopic analysis of Co(II) exchanged into MFI, it was inferred that the fraction of Co(II) (and, b
193 sentially unchanged upon transformation into MFI.
194 with the Multidimensional Fatigue Inventory (MFI).
195  of the presence of de novo DSA (One Lambda, MFI > 1000).
196 approach based on the exfoliation of layered MFI, followed by centrifugation to remove non-exfoliated
197   The recovered group had significantly less MFI in Q1 compared to the two symptomatic groups.
198 requires confirmation in patients with lower MFI (1000-10 000).
199 g the bead of the same HLA-locus with lowest MFI as background) cutoff of 15 combined with an MFI cut
200 r the bead of the same HLA locus with lowest MFI taken as background.
201     Seven patients still had DSA with a mean MFI of 1298 +/- 930 at the last follow-up.
202              High VLA-4 expression (> median MFI), compared with low expression, was associated with
203                                   The median MFI of the immunodominant class I or II DSA in the peak
204 nge, 58.4 to 77.0) and metastatic melanomas (MFI, 87.5; interquartile range, 77.1 to 114.5) (P < 0.00
205 e range, 41.7 to 59.6] to primary melanomas (MFI, 68.8; interquartile range, 58.4 to 77.0) and metast
206                               Mesostructured MFI zeolite nanosheets are established to crystallize no
207 (MFI) >2000 U, in 6 of 10 when the microbead MFI >4000 U.
208              In 8 of 10 cases, the microbead MFI at the time of resolution was greater than at the on
209 ype Pg381 or isogenic major (DPG-3)-, minor (MFI)-, or double fimbriae (MFB)-deficient mutant P. ging
210                                           ML-MFI was first exfoliated by melt compounding and then de
211 s were prepared from a multilamellar MFI (ML-MFI) zeolite.
212 ing up to 35 wt % of solvothermally modified MFI crystals.
213 sing first year peak MFI (pMFI), eight month MFI change (DeltaMFI), and eighteen month MFI trend (MFI
214 th MFI change (DeltaMFI), and eighteen month MFI trend (MFI slope).
215 ng agents were prepared from a multilamellar MFI (ML-MFI) zeolite.
216 m (Mo) atoms into the framework of nanosized MFI zeolite is demonstrated for the first time.
217 tion enthalpy in the tighter confinements of MFI that offsets a less positive activation entropy.
218 ced MFI-polymer adhesion and distribution of MFI crystals.
219 ted in preferentially oriented thin films of MFI, which had sub-12-nm thickness in certain cases.
220 neous distribution of Mo in the framework of MFI nanozeolite, and the presence of Lewis acidity.
221 rdless of WAD recovery, but the magnitude of MFI in the medial portions of the muscles is significant
222                        Bilateral measures of MFI in four quartiles (Q1-Q4; medial to lateral) at cerv
223       MDA has a small effect on reduction of MFI-BG.
224 graft survival was 96% to 100% regardless of MFI (P = NS).
225 graft failure in DSA+ patients regardless of MFI, and higher MFI at 1 year predicts DSA persistence a
226  if transplantation occurs at a threshold of MFI of 500 or less or in those without preformed DSA.
227 alculated panel-reactive antibodies based on MFI of 2000, 4000, and 8000 was unchanged in all patient
228  risk to develop graft damage independent on MFI and requires an individualized risk management.
229 ibenzyl ketone and dibenzyl ketone sorbed on MFI zeolites is examined.
230 membranes that compare favourably with other MFI membranes prepared from existing MFI materials (such
231 nstrating the approach for l- and d-Lys over MFI zeolites at an atomistic resolution, the differentia
232           Highly b-oriented, closely packed, MFI zeolite films are prepared on seeded stainless-steel
233 ctive method was developed to convert parent MFI zeolites with tetrahedral extra-framework Al into Al
234                                   The parent MFI zeolite was prepared by rapid ageing of the zeolite
235 =16; eGFR decline>25%) using first year peak MFI (pMFI), eight month MFI change (DeltaMFI), and eight
236 ee survival was worse in patients with pfDSA MFI >1000, evidenced by a fourfold increase in the risk
237 ctions for specimens with very low positive (MFI < 1,000) or "no-call" H1 results reliably distinguis
238      We show significantly decreased Bio-Rad MFI sensitivity for detection of anti-measles and anti-m
239 easles, mumps, rubella, and VZV, the Bio-Rad MFI was positive in 77.3, 85.4, 84.3, and 91.1% of HCWs,
240                                  The Bio-Rad MFI was positive in 83.7% of HCWs fully vaccinated again
241 ted against measles, mumps, and VZV, Bio-Rad MFI/Bion IFA positivity rates were 77.4%/93%, 84.8%/90.7
242  intergrowth to synthesize high-aspect-ratio MFI nanosheets with a thickness of 5 nanometres (2.5 uni
243         Global normalization further reduced MFI variation to levels near 20%.
244 ardized) operating procedure greatly reduced MFI variation from 62% to 25%.
245               These transformations required MFI seeds or organic templates for FAU parent zeolites,
246 g 39 patients with a lower immunologic risk (MFI between 500 and 3000 at day 0) who received the same
247  correlation between IgG-SAB MFI and C1q-SAB MFI was lowest using undiluted sera and SAB with greater
248 onsequently, the correlation between IgG-SAB MFI and C1q-SAB MFI was lowest using undiluted sera and
249              Prediction and sensitivity SAFB MFI thresholds were determined, respectively, assessing
250 XM results were tightly associated with SAFB MFI values.
251 own to produce high-flux and ultra-selective MFI membranes that compare favourably with other MFI mem
252 thylenediaminetetraacetic acid-treated serum MFI was considered.
253 orthorhombic ( Pnma), typical of high silica MFI, to monoclinic ( P21/ n), as well as an expansion of
254                   However, until now, single MFI nanosheets have been prepared using a multi-step app
255                          Single-unit-cell Sn-MFI, with the detectable Sn uniformly distributed and ex
256      Integrating iDSA HLA class specificity, MFI level, C1q-binding status, and IgG subclasses in a C
257 perior to a model including all IgG subclass MFI (r=0.62).
258                   Combining all IgG subclass MFI and IgGpan MFI only marginally improved the predicti
259 035) compared with treatment initiation (T0) MFI.
260  with the preliminary study, indicating that MFI is spatially concentrated in the medial portions of
261                                          The MFI distribution of DSA+ recipients were as follows: 66%
262                                          The MFI of the immunodominant DSA (iDSA, the DSA with the hi
263                                          The MFI structure offers inherent geometric and internal con
264 nderstanding of HCV-specific immunity at the MFI as well as novel insights into mechanisms that limit
265 and activation of innate immune cells at the MFI.
266  different crystallographic positions in the MFI framework.
267    In addition, the insertion of Mo into the MFI structure induces a symmetry lowering, from orthorho
268 sites in the zeolite HZSM-5, a member of the MFI family of zeolite structures, contradicts the tradit
269            The feasibility of the use of the MFI membranes as an explosive preconcentrator is examine
270 luable chemical intermediates, and therefore MFI-type zeolites are widely used in the chemical indust
271                              Nanometre-thick MFI crystals (nanosheets) have been introduced in pillar
272 uspensions of zeolite nanosheets (3 nm thick MFI layers) were prepared in ethanol following acid trea
273                                      In this MFI zeolite, two distinct (19)F MAS NMR resonances with
274 nd Ti sites become tighter, and is >10 on Ti-MFI.
275 Ti sites are confined within 10-MR pores (Ti-MFI, Ti-CON), likely because of intrapore reactant diffu
276 dies converted to C1q + when concentrated to MFI levels comparable to those observed for AMR+/C1q + s
277 ge (DeltaMFI), and eighteen month MFI trend (MFI slope).
278                A zeolite with structure type MFI is an aluminosilicate or silicate material that has
279 on membranes containing nonporous uncalcined MFI revealed that the performance enhancements are indee
280 e determined pretransplant DSA using various MFI cutoffs, signal-to-background ratios, and combinatio
281           DSA MFI greater than 10 000 versus MFI 1000 to 10 000 at 1 year was also more likely to per
282 iated with the diagnosis of active sAMR were MFI of immunodominant DSA > 4000, MFI of the sum of DSA
283 iated with the diagnosis of active sAMR were MFI of immunodominant DSA >4000, MFI of the sum of DSA >
284                                        While MFI was reported to be concentrated in the medial portio
285 er but only 4% for the group with dnDSA with MFI less than 3,000.
286                     For the dnDSA group with MFI of 3,000 or greater (compared with the group with MF
287 000 or greater (compared with the group with MFI<3,000), the hazard ratio for AMR was 10.6 (95% confi
288 er than 13 (P = 0.004) in DSA+ patients with MFI 1000 to 10 000.
289 y putative chronic AMR in DSA+ patients with MFI from 1000 to 10 000.
290 plication of the method to a 2D zeolite with MFI structure reveals that the exfoliated MFI nanosheet
291 lation of metal clusters (Pt, Ru, Rh) within MFI was achieved by exchanging cationic metal precursors
292  with n = 4 was able to produce also zeolite MFI at highly concentrated conditions.
293 ure and function for aluminosilicate zeolite MFI two-dimensional nanosheets before and after superhea
294   For a medium-pore zeolite, such as zeolite MFI, hydrated hydronium ions consist of eight water mole
295               The higher activity in zeolite MFI with pores smaller than BEA and FAU is caused by a l
296 crystal-thick b-oriented pure silica zeolite MFI films produced by in situ crystallization.
297 surface-treated nanoparticles of the zeolite MFI can be incorporated in situ during growth of a polyc
298                Highly selective thin zeolite MFI membranes are synthesized on porous stainless steel
299                The higher rates with zeolite MFI having pores smaller than those of zeolite BEA for d
300 organic Mg(OH)(2) nanostructures on zeolite (MFI) crystal surfaces in a controlled manner.

 
Page Top